Results 81 to 90 of about 619 (119)

MYC inhibition by Omomyc causes DNA damage and overcomes PARPi resistance in breast cancer.

open access: yesCell Rep
Giuntini F   +26 more
europepmc   +1 more source

[Andersen-Tawil Syndrome, a differential of bidirectional ventricular tachycardia: a case report]. [PDF]

open access: yesArch Peru Cardiol Cir Cardiovasc
Tejeda-Camargo MJ   +4 more
europepmc   +1 more source

Clinical and genetic description of patients with chronic granulomatous disease in a pediatric hospital [PDF]

open access: yesBiomedica
Berriozábal-Villarruel X   +7 more
europepmc   +1 more source

A mixed-methods community needs assessment of Santa Maria and Guadalupe, California. [PDF]

open access: yesDiscov Soc Sci Health
Tseng M   +7 more
europepmc   +1 more source

The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models. [PDF]

open access: yesGenome Med
Herencia-Ropero A   +27 more
europepmc   +1 more source

Evaluación de siete programas bioinformáticos para el análisis terciario de datos genómicos generados a partir de la secuenciación del exoma completo en un grupo piloto de pacientes. [PDF]

open access: yesAdv Lab Med
Bastida-Lertxundi N   +6 more
europepmc   +1 more source

Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment. [PDF]

open access: yesNAR Cancer
Espín R   +39 more
europepmc   +1 more source

[Landau-Kleffner Syndrome: Current Etiopathogenesis and Management]. [PDF]

open access: yesRev Neurol
Méndez-Álvarez AD   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy